ecancermedicalscience

Conference Report

Aspirin for the next generation

2 Apr 2013
Nick Henderson, Tom Smith

First used as an analgesic and antipyretic, investigations into aspirin’s anti-inflammatory effects led to its establishment in 1974 as a drug that altered the activity of platelets to influence the course and incidence of myocardial infarction and cerebrovascular disease. It became the standard in treatment and prevention of vascular disorders.

The 25th International Scientific Meeting on aspirin held at the Royal College of Physicians in London on 24th October 2012 took aspirin into fresh fields, among them cancer, diabetes, dementia and gynaecology.

Related Articles

Lina Cunha, Filipa Fontes, Jotamo Come, Vitória Lobo, Lúcio Lara Santos, Nuno Lunet, Carla Carrilho
Nazik Elmalaika Husain, Amira Burhan, Iman A I Ahmed, Sulma I Mohammed, Nazik Hammad
Priyal Chakravarti, Amita Maheshwari, Shweta Tahlan, Prithviraj Kadam, Sonali Bagal, Suvarna Gore, Nandkumar Panse, Kedar Deodhar, Pankaj Chaturvedi, Rajesh Dikshit, Atul Budukh
Tsion Afework, Birtukan Seid, Aderaw Anteneh, Wondimu Ayele, Seifu Hagos Gebreyesus, Bilal Shikur Endris
Lucrecia Aline Cabral Formigosa, Luciana Ferreira dos Santos, Joana Dulce Cabral Formigosa, Denise da Silva Pinto, Danielle Saraiva Tuma dos Reis, Marcos Valério Santos da Silva